bioRxiv/medRxiv TRiP Review Activity

285 Reviews — eLife — Cancer Biology

Most recent first Previous |  Page 24: Articles 231-240  | Next

Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta
Jian, Y., Kong, L., Xu, H., Huang, X., Li, Y., Shi, D., Xiao, Y., Yang, M., Li, S., Chen, X., Ouyang, Y., Hu, Y., Chen, X., Liu, P., Wei, W.
10.1101/2021.05.09.443305 — Posted: 2021-05-10 — Discussion: 2022-05-11  eLife
Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis
Jiang, L., Yu, H., Ness, S., Mao, P., Guo, F., Tang, J., Guo, Y.
10.1101/2021.08.23.457315 — Posted: 2021-08-24 — Discussion: 2022-05-09  eLife
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes
Doherty, L. M., Mills, C. E., Boswell, S. A., Liu, X., Hoyt, C. T., Gyori, B. M., Buhrlage, S. J., Sorger, P. K.
10.1101/2021.08.06.455458 — Posted: 2021-08-09 — Discussion: 2022-04-29  eLife
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
Fielder, E., Wan, T., Alimohammadiha, G., Ishaq, A., Low, E., Weigand, M. B., Kelly, G., Parker, C., Griffin, B., Jurk, D., Korolchuk, V., von Zglinicki, T., Miwa, S.
10.1101/2021.12.15.472756 — Posted: 2021-12-16 — Discussion: 2022-04-22  eLife
Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation
Aldonza, M. B. D., Cha, J., Yong, I., Ku, J., Lee, D., Sinitcyn, P., Cho, R.-E., Delos Reyes, R. D., Kim, D., Sung, H.-J., Kim, S., Kang, M., Ku, Y., Park, G., Ryu, H. S., Cho, S., Kim, T. M., Kim, P., Cho, J.-Y., Kim, Y.
10.1101/2021.04.21.440719 — Posted: 2021-04-22 — Discussion: 2022-04-06  eLife
The Oncoprotein BCL6 Enables Cancer Cells to Evade Genotoxic Stress
Pang, X., Liu, Y., Feng, J., Yuan, K., Lu, Y., Li, K., Guo, J., Chen, J., Ma, C.
10.1101/2021.06.15.448559 — Posted: 2021-06-15 — Discussion: 2022-03-29  eLife
Air Pollution Particles Hijack Peroxidasin to Disrupt Immunosurveillance and Promote Lung Cancer
Wang, Z., Zhai, Z., Chen, C., Tian, X., Xing, Z., Xing, P., Yang, Y., Zhang, J., Wang, C., Dong, L.
10.1101/2021.12.17.473156 — Posted: 2021-12-20 — Discussion: 2022-03-11  eLife
Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
Vasileva, E., Warren, M., Triche, T. J., Amatruda, J. F.
10.1101/2021.05.25.445683 — Posted: 2021-05-27 — Discussion: 2022-02-22  eLife
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Feola, S., Chiaro, J., Martins, B., Russo, S., Fusciello, M., Ylosmaki, E., Hamdan, F., Feodoroff, M., Antignani, G., Viitala, T., Pesonen, S., Gronholm, M., Branca, R. M. M., Lehtio, J., Cerullo, V.
10.1101/2021.06.08.447483 — Posted: 2021-06-09 — Discussion: 2022-02-20  eLife
COMPARE, an ultra-fast and robust suite for multiparametric screening, identifies phenotypic drug responses in acute myeloid leukemia
Chalabi Hajkarim, M., Karjalainen, E., Osipovitch, M., Dimopoulos, K., Gordon, S. L., Ambri, F., Rasmussen, K. D., Gronbaek, K., Helin, K., Wennerberg, K., Won, K. J.
10.1101/2021.01.08.425880 — Posted: 2021-01-09 — Discussion: 2022-02-16  eLife

Evaluation Sources